
Watch and listen as Raymond T. Chung, MD, reviews key data and updates on hepatitis B management presented at the 2007 Boston liver disease meeting.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss emerging efficacy and safety data on new agents for hepatitis B
- Describe long-term treatment data on the management of hepatitis B
- Summarize strategies for managing patients with resistance or suboptimal responses
- Discuss factors associated with treatment outcomes in hepatitis B